Precision Medicine has been gaining ground as more and more providers prescribe genetics tests and more payers decide to cover it. In this panel, experts in the field will provide a broad overview of where we are and where we need to go to make the promise and potential of precision medicine a reality.
Moderator: Jonathan Hirsch, Syapse Founder
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Speakers:
- Daniel Knecht, MD, Vice President, Transformation Clinical Product, CVS Health
- David Spetzler, PhD, President and Chief Scientific Officer, Caris Life Sciences
- Nephi Walton, MD, Associate Medical Director of Precision Genomics, Intermountain Healthcare